1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of Drug Eluting Stent Market By Product (Polymer Free And Polymer Based), By Scaffold (Platinum Chromium, Cobalt Chromium, Nitinnol, Biodegradable), By Drug (Paclitaxel, Sirolimus, Zotarolimus, Biolimus, Everolimus), By Generation (1st, 2nd, 3rd And 4th Generation), By Application (Peripheral Vascular Diseases, Coronary Diseases), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers) And By Region (Global Market Forecast To 2027)

Global Market Analysis Of Drug Eluting Stent Market By Product (Polymer Free And Polymer Based), By Scaffold (Platinum Chromium, Cobalt Chromium, Nitinnol, Biodegradable), By Drug (Paclitaxel, Sirolimus, Zotarolimus, Biolimus, Everolimus), By Generation (1st, 2nd, 3rd And 4th Generation), By Application (Peripheral Vascular Diseases, Coronary Diseases), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers) And By Region (Global Market Forecast To 2027)

Publication Month: Feb 2020 | No. of Pages: 125 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

The Global Drug-Eluting Stent market is estimated to reach $ 8.54 billion by 2027 from $ 5.65 billion in 2019; growing at a CAGR of 5.2% from 2019 to 2027.

The stent is a small tube-like structure device which is to be inserted into the arteries to allow the normal flow of oxygen and blood to the heart and prevent blockage. Stents is also used in other structures such as carotid arteries, esophagus, ureters, bile duct, etc.

Drug-Eluting Stent is coated with a polymer that releases the drug slowly over time to prevent the regenerative blockages.

Market Dynamics

The Global Drug-Eluting Stent market is primarily driven by factors such as increasing population with cardiovascular diseases, increasing awareness about cardiovascular medical devices, growing health care infrastructure, technological advancement, increasing spending on research and development, etc. are some of the forces that drive the market.

Market Segmentation

The Global Drug-Eluting Stent market is mainly classified based on product type, scaffold, drug, generation, application, end-user, and by region.

Based on the Product Type segment, the market is categorized into Polymer free and polymer-based. Among them, Polymer Based segment dominated the market.

Based on Scaffold, the market is further segmented into Platinum Chromium, Cobalt-Chromium, Nitinol, Biodegradable, others. Among them, the Cobalt-Chromium segment dominated the market.

Based on the Drug, the market is further segmented into Paclitaxel, Sirolimus, Zotarolimus, Everolimus, Biolimus, etc. Among them, the Sirolimus segment has dominated the market. Sirolimus is a highly used drug for stents. Sirolimus is the most preferred drug by the surgeon.

Based on the Generation, the market is further segmented into 1st generation, 2nd generation, 3rd generation, and 4th generation. Among them, the 3rd generation drug-eluting stent segment dominated the market.

Based on the Application, the market is further segmented into Coronary Diseases and Peripheral Vascular Diseases. Among them, the Peripheral Vascular Disease segment dominated the market.

Based on the End User, the market is further segmented into Hospitals, Cardiac Care Centers and Ambulatory Surgical Centers. Among them, Ambulatory Surgical Centers dominated the market. 

Regional Analysis

Based on geography, the Global Drug-Eluting Stent market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Among all the regions, Europe has generated the highest revenue. Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Key players operating in the Drug-Eluting Stent market include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Medtronic plc, Biosensors International Group Ltd., MicroPort Scientific Corporation, Terumo Corporation, STENTYS SA, Medinol Ltd., Cook group, other players.

Drug-Eluting Stent Market Key Segments:

By Product Type

  • Polymer Free
  • Polymer-Based
    • Biodegradable Polymers
    • Durable Polymers

By Scaffold

  • Platinum Chromium
  • Cobalt-Chromium
  • Nitinol
  • Biodegradable
  • Others

By Drug

  • Paclitaxel
  • Sirolimus
  • Zotarolimus
  • Biolimus
  • Everolimus
  • Others

By Generation

  • 1st Generation
  • 2nd Generation
  • 3rd Generation
  • 4th Generation

By Application

  • Peripheral Vascular Diseases
  • Coronary Diseases

By End-User

  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1 Market Overview

1.1 Drug Eluting Stent Introduction

1.2 Market Analysis by Product Type

1.2.1 Overview: Global Drug Eluting Stent Revenue by Product Type: 2018 VS 2020 VS 2027

1.2.2 Polymer Free

1.2.3 Polymer Based

1.2.3.1 Biodegradable Polymers

1.2.3.2 Durable Polymers

1.3 Market Analysis by Scaffold

1.3.1 Overview: Global Drug Eluting Stent Revenue by Scaffold: 2018 VS 2020 VS 2027

1.3.2 Platinum Chromium

1.3.3 Cobalt Chromium

1.3.4 Nitinnol

1.3.5 Biodegradable

1.3.6 Others

1.4 Market Analysis by Drug

1.4.1 Overview: Global Drug Eluting Stent Revenue by Drug: 2018 VS 2020 VS 2027

1.4.2 Paclitaxel

1.4.3 Sirolimus

1.4.4 Zotarolimus

1.4.5 Biolimus

1.4.6 Everolimus

1.4.7 Others

1.5 Market Analysis by Generation

1.5.1 Overview: Global Drug Eluting Stent Revenue by Generation: 2018 VS 2020 VS 2027

1.5.2 1st Generation

1.5.3 2nd Generation

1.5.4 3rd Generation

1.5.5 4th Generation

1.6 Market Analysis by Application

1.6.1 Overview: Global Drug Eluting Stent Revenue by Application: 2018 VS 2020 VS 2027

1.6.2 Peripheral Vascular Diseases

1.6.3 Coronary Diseases 1.6 Market Analysis by End User

1.6.1 Overview: Global Drug Eluting Stent Revenue by End User: 2018 VS 2020 VS 2027

1.6.2 Hospitals

1.6.3 Cardiac Care Centers

1.6.4 Ambulatory Surgical Centers

1.7 Overview of Global Drug Eluting Stent Market

1.7.1 Global Drug Eluting Stent Market Status and Outlook (2018-2027)

1.7.2 North America (United States, Canada and Mexico)

1.7.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.7.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.7.5 South America, Middle East & Africa

1.8 Market Dynamics

1.8.1 Market Opportunities

1.8.2 Market Risk

1.8.3 Market Driving Force

2 Manufacturers Profiles

2.1 Biotronik

2.1.1 Biotronik Details

2.1.2 Biotronik Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Biotronik SWOT Analysis

2.1.4 Biotronik Product and Services

2.1.5 Biotronik Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.2 Abbott Laboratories

2.2.1 Abbott Laboratories Details

2.2.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Abbott Laboratories SWOT Analysis

2.2.4 Abbott Laboratories Product and Services

2.2.5 Abbott Laboratories Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.3 Medtronic Plc

2.3.1 Medtronic Plc Details

2.3.2 Medtronic Plc Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Medtronic Plc SWOT Analysis

2.3.4 Medtronic Plc Product and Services

2.3.5 Medtronic Plc Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.4 Boston Scientific Corporation

2.4.1 Boston Scientific Corporation Details

2.4.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Boston Scientific Corporation SWOT Analysis

2.4.4 Boston Scientific Corporation Product and Services

2.4.5 Boston Scientific Corporation Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.5 Biosensors International Group Ltd.

2.5.1 Biosensors International Group Ltd. Details

2.5.2 Biosensors International Group Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Biosensors International Group Ltd. SWOT Analysis

2.5.4 Biosensors International Group Ltd. Product and Services

2.5.5 Biosensors International Group Ltd. Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.6 MicroPort Scientific Corporation

2.6.1 MicroPort Scientific Corporation Details

2.6.2 MicroPort Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 MicroPort Scientific Corporation SWOT Analysis

2.6.4 MicroPort Scientific Corporation Product and Services

2.6.5 MicroPort Scientific Corporation Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.7 Terumo Corporation

2.7.1 Terumo Corporation

2.7.2 Terumo Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Terumo Corporation SWOT Analysis

2.7.4 Terumo Corporation Product and Services

2.7.5 Terumo Corporation Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.8 STENTYS SA

2.8.1 STENTYS SA Details

2.8.2 STENTYS SA Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 STENTYS SA SWOT Analysis

2.8.4 STENTYS SA Product and Services

2.8.5 STENTYS SA Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.9 Medinol Ltd.

2.9.1 Medinol Ltd. Details

2.9.2 Medinol Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Medinol Ltd. SWOT Analysis

2.9.4 Medinol Ltd. Product and Services

2.9.5 Medinol Ltd. Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.10 Cook Group

2.10.1 Cook Group

2.10.2 Cook Group Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Cook Group SWOT Analysis

2.10.4 Cook Group Product and Services

2.10.5 Cook Group Drug Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Drug Eluting Stent Sales and Market Share by Manufacturer (2018-2019-2020)

3.2 Global Drug Eluting Stent Revenue and Market Share by Manufacturer (2018-2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Drug Eluting Stent Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Drug Eluting Stent Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Drug Eluting Stent Sales, Revenue and Market Share by Regions

4.1.1 Global Drug Eluting Stent Sales and Market Share by Regions (2018-2020)

4.1.2 Global Drug Eluting Stent Revenue and Market Share by Regions (2018-2020)

4.2 North America Drug Eluting Stent Sales and Growth Rate (2018-2020)

4.3 Europe Drug Eluting Stent Sales and Growth Rate (2018-2020)

4.4 Asia-Pacific Drug Eluting Stent Sales and Growth Rate (2018-2020)

4.5 South America Drug Eluting Stent Sales and Growth Rate (2018-2020)

4.6 Middle East and Africa Drug Eluting Stent Sales and Growth Rate (2018-2020)

5 North America by Country

5.1 North America Drug Eluting Stent Sales, Revenue and Market Share by Country

5.1.1 North America Drug Eluting Stent Sales and Market Share by Country (2018-2020)

5.1.2 North America Drug Eluting Stent Revenue and Market Share by Country (2018-2020)

5.2 United States Drug Eluting Stent Sales and Growth Rate (2018-2020)

5.3 Canada Drug Eluting Stent Sales and Growth Rate (2018-2020)

5.4 Mexico Drug Eluting Stent Sales and Growth Rate (2018-2020)

6 Europe by Country

6.1 Europe Drug Eluting Stent Sales, Revenue and Market Share by Country

6.1.1 Europe Drug Eluting Stent Sales and Market Share by Country (2018-2020)

6.1.2 Europe Drug Eluting Stent Revenue and Market Share by Country (2018-2020)

6.2 Germany Drug Eluting Stent Sales and Growth Rate (2018-2020)

6.3 UK Drug Eluting Stent Sales and Growth Rate (2018-2020)

6.4 France Drug Eluting Stent Sales and Growth Rate (2018-2020)

6.5 Russia Drug Eluting Stent Sales and Growth Rate (2018-2020)

6.6 Italy Drug Eluting Stent Sales and Growth Rate (2018-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Drug Eluting Stent Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Drug Eluting Stent Sales and Market Share by Regions (2018-2020)

7.1.2 Asia-Pacific Drug Eluting Stent Revenue and Market Share by Regions (2018-2020)

7.2 China Drug Eluting Stent Sales and Growth Rate (2018-2020)

7.3 Japan Drug Eluting Stent Sales and Growth Rate (2018-2020)

7.4 Korea Drug Eluting Stent Sales and Growth Rate (2018-2020)

7.5 India Drug Eluting Stent Sales and Growth Rate (2018-2020)

7.6 Southeast Asia Drug Eluting Stent Sales and Growth Rate (2018-2020)

7.7 Australia Drug Eluting Stent Sales and Growth Rate (2018-2020)

8 South America by Country

8.1 South America Drug Eluting Stent Sales, Revenue and Market Share by Country

8.1.1 South America Drug Eluting Stent Sales and Market Share by Country (2018-2020)

8.1.2 South America Drug Eluting Stent Revenue and Market Share by Country (2018-2020)

8.2 Brazil Drug Eluting Stent Sales and Growth Rate (2018-2020)

8.3 Argentina Drug Eluting Stent Sales and Growth Rate (2018-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Drug Eluting Stent Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Drug Eluting Stent Sales and Market Share by Country (2018-2020)

9.1.2 Middle East & Africa Drug Eluting Stent Revenue and Market Share by Country (2018-2020)

9.2 Saudi Arabia Drug Eluting Stent Sales and Growth Rate (2018-2020)

9.3 Turkey Drug Eluting Stent Sales and Growth Rate (2018-2020)

9.4 Egypt Drug Eluting Stent Sales and Growth Rate (2018-2020)

9.5 South Africa Drug Eluting Stent Sales and Growth Rate (2018-2020)

10 Market Segment by Product Type

10.1 Global Drug Eluting Stent Sales and Market Share by Product Type (2018-2020)

10.2 Global Drug Eluting Stent Revenue and Market Share by Product Type (2018-2020)

10.3 Global Drug Eluting Stent Price by Product Type (2018-2020)

11 Global Drug Eluting Stent Market Segment by Scaffold

11.1 Global Drug Eluting Stent Sales Market Share by Scaffold (2018-2020)

11.2 Global Drug Eluting Stent Revenue Market Share by Scaffold (2018-2020)

11.3 Global Drug Eluting Stent Price by Scaffold (2018-2020)

12 Market Segment by Drug

12.1 Global Drug Eluting Stent Sales and Market Share by Drug (2018-2020)

12.2 Global Drug Eluting Stent Revenue and Market Share by Drug (2018-2020)

12.3 Global Drug Eluting Stent Price by Drug (2018-2020)

13 Market Segment by Generation

13.1 Global Drug Eluting Stent Sales and Market Share by Generation (2018-2020)

13.2 Global Drug Eluting Stent Revenue and Market Share by Generation (2018-2020)

13.3 Global Drug Eluting Stent Price by Generation (2018-2020)

14 Market Segment by Application

14.1 Global Drug Eluting Stent Sales and Market Share by Application (2018-2020)

14.2 Global Drug Eluting Stent Revenue and Market Share by Application (2018-2020)

14.3 Global Drug Eluting Stent Price by Application (2018-2020)

15 Market Segment by End User

15.1 Global Drug Eluting Stent Sales and Market Share by End User (2018-2020)

15.2 Global Drug Eluting Stent Revenue and Market Share by End User (2018-2020)

15.3 Global Drug Eluting Stent Price by End User (2018-2020)

16 Market Forecast

16.1 Global Drug Eluting Stent Sales, Revenue and Growth Rate (2021-2027)

16.2 Drug Eluting Stent Market Forecast by Regions (2021-2027)

16.2.1 North America Drug Eluting Stent Market Forecast (2021-2027)

16.2.2 Europe Drug Eluting Stent Market Forecast (2021-2027)

16.2.3 Asia-Pacific Drug Eluting Stent Market Forecast (2021-2027)

16.2.4 South America Drug Eluting Stent Market Forecast (2021-2027)

16.2.5 Middle East & Africa Drug Eluting Stent Market Forecast (2021-2027)

16.3 Drug Eluting Stent Market Forecast by Product Type (2021-2027)

16.3.1 Global Drug Eluting Stent Sales Forecast by Product Type (2021-2027)

16.3.2 Global Drug Eluting Stent Market Share Forecast by Product Type (2021-2027)

16.4 Drug Eluting Stent Market Forecast by Scaffold (2021-2027)

16.4.1 Global Drug Eluting Stent Sales Forecast by Scaffold (2021-2027)

16.4.2 Global Drug Eluting Stent Market Share Forecast by Scaffold (2021-2027) 16.5 Drug Eluting Stent Market Forecast by Drug (2021-2027)

16.5.1 Global Drug Eluting Stent Sales Forecast by Drug (2021-2027)

16.5.2 Global Drug Eluting Stent Market Share Forecast by Drug (2021-2027) 16.6 Drug Eluting Stent Market Forecast by Generation (2021-2027)

16.6.1 Global Drug Eluting Stent Sales Forecast by Generation (2021-2027)

16.6.2 Global Drug Eluting Stent Market Share Forecast by Generation (2021-2027) 16.7 Drug Eluting Stent Market Forecast by Application (2021-2027)

16.7.1 Global Drug Eluting Stent Sales Forecast by Application (2021-2027)

16.7.2 Global Drug Eluting Stent Market Share Forecast by Application (2021-2027) 16.8 Drug Eluting Stent Market Forecast by End User (2021-2027)

16.6.1 Global Drug Eluting Stent Sales Forecast by End User (2021-2027)

16.6.2 Global Drug Eluting Stent Market Share Forecast by End User (2021-2027)

17 Sales Channel, Distributors, Traders and Dealers

17.1 Sales Channel

17.1.1 Direct Marketing

17.1.2 Indirect Marketing

17.2 Distributors, Traders and Dealers

18 Research Findings and Conclusion

19 Appendix

19.1 Methodology

19.2 Data Source

19.3 Disclaimer

19.4 About US

This document has been edited with the instant web content composer. The online instant HTML converter make a great resource that will help you a lot in your work. Save this link or add it to your bookmarks.

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets